2004•Zhongguo shouyi ke-jiRequires access

Study on pharmacokinetics of sulfamonomethoxine long-acting injection in pigs

Zhuo Qu

Open publisher page 0 citations

Abstract

The objective of the study was to investigate pharmacokinetic properties of sulfamonomethoxine long-acting injection in pigs. Twelve pigs were allotted to two groups at 6 pigs per group. The pigs in two groups were administered muscularly with sulfamonomethoxine long-acting injection A and sulfa- monomethoxine long-acting injection B respectively at the dose of 0.4 mL/kg body weight. Blood samples at 5 mL each time were collected from front cavity veins at different intervals after administration. The drug concentrations in plasma were analyzed by HPLC, and then the pharmacokinetic parameters were calculated by using MCPKP software. The results of the sulfamonomethoxine long-acting injection A were as follows: C_(max)=22.30 μg/mL±2.09 μg/mL, AUC=533.58 μg/(mL·h)±30.76 μg/(mL·h) and t_(1/2)_β=(20.20) h±5.31 h. The results of the sulfamonomethoxine long-acting injection B were as follows: C_(max)=15.96 μg/mL±2.36 μg/mL, AUC=199.91 μg/(mL·h)±11.31 μg/(mL·h) and t_(1/2)_β=9.81 h±1.03 h.

About this research paper

What this paper is about

The objective of the study was to investigate pharmacokinetic properties of sulfamonomethoxine long-acting injection in pigs. Twelve pigs were allotted to two groups at 6 pigs per group. The pigs in two groups were administered muscularly with sulfamonomethoxine long-acting injection A and sulfa- monomethoxine long-acting injection B respectively at the dose of 0.4 mL/kg body weight. Blood samples at 5 mL each time were collected from front cavity veins at different intervals after administration. The drug concentrations in plasma were analyzed by HPLC, and then the pharmacokinetic parameters were calculated by using MCPKP software. The results of the sulfamonomethoxine long-acting injection A were as follows: C_(max)=22.30 μg/mL±2.09 μg/mL, AUC=533.58 μg/(mL·h)±30.76 μg/(mL·h) and t_(1/2)_β=(20.20) h±5.31 h. The results of the sulfamonomethoxine long-acting injection B were as follows: C_(max)=15.96 μg/mL±2.36 μg/mL, AUC=199.91 μg/(mL·h)±11.31 μg/(mL·h) and t_(1/2)_β=9.81 h±1.03 h.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The objective of the study was to investigate pharmacokinetic properties of sulfamonomethoxine long-acting injection in pigs. Twelve pigs were allotted to two groups at 6 pigs per group. The pigs in two groups were administered muscularly with sulfamonomethoxine long-acting injection A and sulfa- monomethoxine long-acting injection B respectively at the dose of 0.4 mL/kg body weight. Blood samples at 5 mL each time were collected from front cavity veins at different intervals after administration. The drug concentrations in plasma were analyzed by HPLC, and then the pharmacokinetic parameters were calculated by using MCPKP software. The results of the sulfamonomethoxine long-acting injection A were as follows: C_(max)=22.30 μg/mL±2.09 μg/mL, AUC=533.58 μg/(mL·h)±30.76 μg/(mL·h) and t_(1/2)_β=(20.20) h±5.31 h. The results of the sulfamonomethoxine long-acting injection B were as follows: C_(max)=15.96 μg/mL±2.36 μg/mL, AUC=199.91 μg/(mL·h)±11.31 μg/(mL·h) and t_(1/2)_β=9.81 h±1.03 h.

Key concepts: Pharmacokinetics, High-performance liquid chromatography, Pharmacology, Plasma concentration, Body weight, Chemistry, Chromatography, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on pharmacokinetics of sulfamonomethoxine long-acting injection in pigs — Research Paper | ScholarLens